71 West Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
16,058
+5,071
+46% +$594K 0.07% 82
2026
Q1
$1.32M Buy
10,987
+1,879
+21% +$217K 0.06% 82
2025
Q4
$959K Buy
+9,108
New +$855K 0.04% 89

Other funds holding MRK

71 West Capital Partners's MRK Position: Q2 2026 in Review

71 West Capital Partners increased its Merck (MRK) stake by 46% in Q2 2026, buying an estimated $594K and bringing the position to 16,058 shares worth $2.06M. The position accounts for 0.07% of the portfolio, ranked #82.

71 West Capital Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 71 West Capital Partners held 16,058 shares of Merck worth $2.06M as of Q2 2026.
  • 71 West Capital Partners bought 5,071 Merck shares in Q2 2026, an estimated $594K.
  • Merck made up 0.07% of 71 West Capital Partners's portfolio in Q2 2026, its #82 holding.
  • 71 West Capital Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.